However, in tumors that rely on G2/M checkpoint arrest for DNA damage repair, preclinical and clinical studies that explored WEE1 inhibition showed a reduction in the growth of a wide variety of cancers, including breast cancer. Here, WEE1 is linked to breast carcinoma.